TalkMed Group (SGX:5G3) EV-to-EBIT : 11.61 (As of May. 15, 2024)

View and export this data going back to 2014. Start your Free Trial

What is TalkMed Group EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, TalkMed Group's Enterprise Value is S$443.31 Mil. TalkMed Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was S$38.17 Mil. Therefore, TalkMed Group's EV-to-EBIT for today is 11.61.

The historical rank and industry rank for TalkMed Group's EV-to-EBIT or its related term are showing as below:

SGX:5G3' s EV-to-EBIT Range Over the Past 10 Years
Min: 1.97 Med: 14.26 Max: 22.14
Current: 11.61

During the past 12 years, the highest EV-to-EBIT of TalkMed Group was 22.14. The lowest was 1.97. And the median was 14.26.

SGX:5G3's EV-to-EBIT is ranked better than
72.6% of 427 companies
in the Healthcare Providers & Services industry
Industry Median: 18.26 vs SGX:5G3: 11.61

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. TalkMed Group's Enterprise Value for the quarter that ended in Dec. 2023 was S$416.92 Mil. TalkMed Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was S$38.17 Mil. TalkMed Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 9.16%.

TalkMed Group EV-to-EBIT Historical Data

The historical data trend for TalkMed Group's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TalkMed Group EV-to-EBIT Chart

TalkMed Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

14.63

19.71

15.86

12.12

10.92

TalkMed Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial															15.86	-	12.12	-	10.92

Competitive Comparison of TalkMed Group's EV-to-EBIT

For the Medical Care Facilities subindustry, TalkMed Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TalkMed Group's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TalkMed Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where TalkMed Group's EV-to-EBIT falls into.

TalkMed Group EV-to-EBIT Calculation

TalkMed Group's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	443.313	/	38.172
	=	11.61

TalkMed Group's current Enterprise Value is S$443.31 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. TalkMed Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was S$38.17 Mil.

TalkMed Group (SGX:5G3) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

TalkMed Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	38.172	/	416.9176
	=	9.16 %

TalkMed Group's Enterprise Value for the quarter that ended in Dec. 2023 was S$416.92 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. TalkMed Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was S$38.17 Mil.

TalkMed Group EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of TalkMed Group's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

TalkMed Group (SGX:5G3) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TalkMed Group Ltd (SGX:5G3) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

3 Mount Elizabeth, Mount Elizabeth Hospital Level 2, Singapore, SGP, 228510

Website

https://www.talkmed.com.sg

TalkMed Group Ltd operates as an investment holding company. It is a provider of medical oncology, stem cell transplants and palliative care services, serving patients in Singapore and the region. Outside Singapore, the Group operates in Vietnam, Hong Kong and the People's Republic of China. The activities of the company are the provision of medical oncology services and palliative care healthcare services in Singapore. It is organized into three reportable operating segments, Oncology Services, Stem Cells Services and Cellular and gene therapy-related products and services. The company has operational footprints across Singapore, Hong Kong and Vietnam of which Singapore contributes the vast majority of total revenue. It generates maximum revenue from the Oncology services segment.

TalkMed Group (SGX:5G3) Headlines

No Headlines